NEW YORK, May 17, 2013 /PRNewswire/ -- Sudler & Hennessey, one of the leading global healthcare communication agencies, announces an agreement between Sudler's eHealth Group and NextGxDx, an online genetic testing marketplace for healthcare providers and hospitals.
Emerging trends in healthcare focus on cost, quality, and access to care and information. As personalized medicine continues to expand, and as new genetic tests are introduced daily, integration of these tests into clinical practice is a growing challenge for healthcare providers. The innovative NextGxDx solution consolidates and curates data on genetic tests to help users compare and order tests in a simple way that reduces paperwork and streamlines the ordering process leading to more time with their patient.
This is especially critical now as the NIH announced that Genetests.org, one of the most commonly used gene test databases, is being discontinued on June 4, 2013.
"Working with the Sudler eHealth Group is an excellent opportunity to drive awareness, and Sudler's knowledge of physician engagement is another innovative step for us to take in connecting with healthcare professionals. Collectively, NextGxDx and Sudler eHealth will drive change in the way genetic tests are researched and ordered," said Mark Harris, PhD, CEO of NextGxDx.According to Cassandra Sinclair, Managing Director eHealth Group, "We're very excited to be working with NextGxDx as they build a new marketplace for genetic testing that will create transparency in the industry. Our strategic expertise, integrated insights, and creative capabilities, along with our decades of healthcare experience, will significantly help NextGxDx meet the next milestone". The Sudler eHealth Group partners with health information technology (HIT) companies to effectively tap into the healthcare market through strategic communications, education, and training of healthcare professionals. Using its strategic, integrated insights and capabilities, they have moved markets for their pharmaceutical clients and will use this foundation and experience to help HIT companies drive market change at the point of care.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts